30.4 C
Vientiane
Monday, July 21, 2025
spot_img
Home Blog Page 211

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

  • DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with ORR of 84.2%
  • DZD6008, a BBB-penetrant 4th generation EGFR TKI, showed encouraging and durable anti-tumor activity with favorable safety and tolerability as a monotherapy in heavily pre-treated non-small cell lung cancer (NSCLC) patients with EGFR-mutations

SHANGHAI, May 26, 2025 /PRNewswire/ — Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical study results of its investigational drugs DZD8586 and DZD6008 at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies focus on B-cell non-Hodgkin lymphomas (B-NHLs) and non-small cell lung cancer (NSCLC) two disease areas Dizal has approved drugs and strong clinical pipeline.

DZD8586: A Potential Novel Therapeutic Option for Patients with B-NHL

A pooled analysis of two phase I/II studies of DZD8586 in CLL/SLL patients after treatment with covalent or non-covalent BTK inhibitors and BTK degraders (Abstract #7010) was selected for an oral presentation:

  • An objective response rate (ORR) of 84.2% was achieved. Tumor response was observed in patients previously treated with BTK inhibitors and BCL-2 inhibitors, with response rates of 82.4% and 83.3%, respectively.
  • Tumor response was observed irrespective of prior covalent/non-covalent BTK inhibitor, BTK degrader, or BCL-2 inhibitor treatment, and in patients with classic BTK resistance mutations (C481X) as well as other BTK mutations, including kinase-dead mutations.
  • Response was durable, with an estimated 9-month duration of response (DOR) rate of 83.3%.

Prof. Jianyong Li, MD, PhD at Jiangsu Province Hospital, and the leading principal investigator of the study, said,DZD8586 has shown promising antitumor activity in patients with relapsed/refractory CLL/SLL. By targeting both BTK-dependent and -independent signaling pathways, it could overcome resistance driven by target depletion or bypass activation, addressing significant limitations of current BTK inhibitors. We look forward to continued data readout from ongoing clinical studies.”

In addition, a Phase II study of DZD8586 as monotherapy in relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) (Abstract # e19050) will also be presented at the conference. Patients recruited in the trial had received 1-4 prior lines of therapy, and all were treated with anthracycline-and CD20-antibody based chemoimmunotherapy. At the doses of 50 mg and 75 mg QD, DZD8586 demonstrated promising antitumor activity and a manageable safety profile. Tumor responses were observed in both germinal center B-cell-like (GCB) and non-GCB subtypes. Updated results from this study will be disclosed at the 2025 European Hematology Association (EHA) Annual Congress.

Prof. Lugui Qiu, MD, PhD at Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, the leading principal investigator of this study, said, “Treatment resistance in relapsed/refractory DLBCL remains a major clinical challenge. DZD8586, a non-covalent dual LYN/BTK inhibitor, has shown activity in both GCB and non-GCG subtypes, an important feature. With full BBB penetration and a favorable safety profile, it also shows promise in patients with CNS involvement, who typically confront a poor prognosis.”

DZD6008: A 4th generation EGFR TKI Poised to Address Unmet Needs in NSCLC

The presentation at ASCO 2025 will feature promising pre-clinical and early clinical data from an ongoing Phase I/II TIAN-SHAN2 study of DZD6008 in patients with EGFRm NSCLC (Abstract #8616). Preclinical studies showed that DZD6008 was potent against EGFR mutations, including single (L858R/19del), double (T790M and L858R/19del), and triple mutations (C797X, T790M and 19del), with good selectivity (> 50-fold) over wild-type EGFR.

As of March 31, 2025, a total of 12 EGFRm NSCLC patients were enrolled in the study during the dose escalation phase. The median number of prior lines of therapy was 4.5 (range 2-8). DZD6008 monotherapy demonstrated encouraging and durable antitumor activity with good tolerability in this heavily pre-treated population. Ten patients (83.3%) showed target lesion shrinkage with DZD6008 treatment. Partial response (PR) was observed at ≥20 mg. In line with preclinical findings, DZD6008 exhibited excellent BBB penetration, as well as sustained efficacy in patients with brain metastases. The ratio of measured free drug concentrations in CSF over plasma is over 1.0.

Prof. Mengzhao Wang, MD, PhD at Peking Union Medical College Hospital, the leading principal investigator of the study said,DZD6008 is a novel, highly selective, full-BBB penetrant EGFR TKI with broad-spectrum of activity against different EGFR mutations. The clinical data revealed at ASCO 2025 suggested that DZD6008 has good antitumor activity and tolerability in EGFRm NSCLC patients who were resistant to EGFR TKIs, especially their durable remission effect on metastatic brain lesions. The ongoing TIAN-SHAN2 study aims to further validate these findings in a broader patient population.”

“The clinical data on DZD8586 and DZD6008 presented at this year’s ASCO further highlight our strong R&D capabilities and competitive edge in tackling difficult-to-treat hematologic malignancies and lung cancer. The significant efficacy data and encouraging safety profile give us confidence to push forward to accelerate its clinical development programs,” said Xiaolin Zhang, PhD, CEO of Dizal.

About DZD8586
DZD8586 is a first-in-class, non-covalent, LYN/BTK dual inhibitor with full blood-brain barrier (BBB) penetration, designed as a potential treatment option for B-cell non-Hodgkin lymphoma (B-NHL).

While Bruton’s Tyrosine Kinase (BTK) inhibitors have been approved for the treatment of B-NHL, resistance can arise through two major mechanisms: the BTK C481X mutation and BTK-independent BCR signaling pathway activation. Currently, there is no targeted therapy available to address both resistance mechanisms, posing an urgent clinical challenge. Although BTK degraders have shown encouraging efficacy in early clinical studies, mutation-related resistance has been reported, and degrader-related toxicities may affect long-term clinical application.

DZD8586 has high selectivity against other TEC family kinases (TEC, ITK, TXK and BMX). By targeting BTK and LYN, it blocks both BTK-dependent and -independent BCR-signaling pathways, effectively inhibiting tumor growth of B-NHLs in cell lines and in animal models. Phase I clinical trial suggests that DZD8586 exhibits favorable PK properties, good central nervous system (CNS) permeability, complete blockade of BCR signaling, and encouraging anti-tumor efficacy with good safety and tolerability in patients with B-NHL.

About DZD6008
DZD6008 is a novel, highly selective, full-BBB penetrant EGFR TKI, designed as a potential treatment option for advanced EGFR mutation positive (EGFRm) NSCLC.

Non-small cell lung cancer is the leading cause of cancer death in the world. Epidermal growth factor receptor (EGFR) gene is one of the most common driver genes for NSCLC. Multiple agents can be used to treat patients with EGFR mutated NSCLC who develop resistance to EGFR tyrosine kinase inhibitors (TKIs), but the clinical outcome was not satisfactory. Brain metastases (BM) are a leading cause of death and disease progression for NSCLC. Approximately 23%-30% of NSCLC patients are synchronous BM at their initial diagnosis. Previous studies reported that the 3-year cumulative rate of BMs ranges from 29.4% to 60.3% in patients with mutated EGFR.

Currently, the clinical benefits of existing treatments for third-generation EGFR TKI-resistant NSCLC are limited and DZD6008 is expected to fill the unmet medical needs. DZD6008 effectively inhibits EGFR-mutated tumor growth in cell lines and in animal models. Previous clinical studies have validated the design concept of the molecule and suggest that DZD6008 demonstrates good safety and efficacy in NSCLC patients with brain metastases who had failed third-generation EGFR TKI therapy or multiple lines of pre-treatments.

About Dizal
Dizal is a biopharmaceutical company, dedicated to the discovery, development and commercialization of differentiated therapeutics for the treatment of cancer and immunological diseases. The company aims to develop first-in-class and groundbreaking new medicines, and further address unmet medical needs worldwide. Deeply rooted in translational science and molecular design, it has established an internationally competitive portfolio with two leading assets in global pivotal studies, both of which have already been launched in China.

To learn more about Dizal, please visit www.dizalpharma.com, or follow us on Linkedin or X.

Forward-Looking Statements
This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, and “intend” and similar expressions, as they relate to Dizal, are intended to identify certain forward-looking statements. Dizal does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections, and understandings of the management of Dizal with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties, and other factors, some of which are beyond Dizal’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Dizal’s competitive environment, and political, economic, legal, and social conditions.

Dizal, the Directors, and the employees of Dizal assume (a) no obligation to correct or update the forward-looking statements contained on this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turnout to be incorrect.

Contacts
Investor Relations: ir@dizalpharma.com
Business Development: bd@dizalpharma.com
Media Contact: pr@dizalpharma.com

Esaote: The new MyLab™Heron ultrasound scanner for veterinary physicians had its world premiere at the SCIVAC Rimini 2025 Congress

GENOA, Italy, May 26, 2025 /PRNewswire/ — Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heron ultrasound system at the Congress organized in Rimini from May 23 to 25 May by SCIVAC, the largest Veterinary Scientific Society in Italy, the objective of which is the scientific and professional education of veterinarians.

The new MyLab™Heron ultrasound scanner
The new MyLab™Heron ultrasound scanner

MyLab™Heron is the latest result of Esaote’s research activity in high-performance portable ultrasound systems, in which the Company has now been recognized for over 30 years and where it stands out for its comprehensive product portfolio and innovative solutions. 

“Veterinary physicians,” stated Erminio Bassi, Esaote Vet Business Manager, “are always looking for tools that improve accuracy and efficiency, and this new ultrasound system meets these needs perfectly.”

MyLab™Heron is inspired by the animal from which it takes its characteristics of precision and ease of movement, even in challenging conditions, and is a portable system that combines superior performance, ease of use and mobility, including a fully cleanable touch interface. Access to all functions, from simple to advanced, is simple, intuitive and customizable, while its compact size and long-lasting battery make it ideal in any clinical setting.

Workflows are designed to reduce the number of actions and to enable the veterinarian to focus on caring for the animal. Advanced technology and dedicated veterinary solutions make the diagnostic process simple and reliable. The result is faster and more accurate decisions. By analyzing real-time imaging data, artificial intelligence features built into the system reduce operator input, improving overall workflow and productivity.

Similarly, MyLab™Heron offers high-resolution imaging in both superficial and deeper areas, thanks to the wide range of probes available. All this makes it possible to scan animals of any size in all applications, from general imaging to cardiology, from the musculoskeletal system to reproduction, providing unparalleled clarity. A powerful tool designed to support veterinarians working in clinics, hospitals and independently.

MyLab™Heron supplements and enriches the range of Esaote ultrasound scanners dedicated to veterinary medicine, of which MyLab™Fox and MyLab™Panther are well-established, widely recognized benchmarks in international markets. They demonstrate the attention to innovation and detail with which Esaote intends to make veterinary care increasingly accessible and decisive, to improve proximity to animals and the people who love them.

Esaote also supports veterinary physicians in diagnostic imaging with training programs and education, from webinars to live events; it is convinced that its vision of care based on sharing, research, and discussion with experts can help improve the future of veterinary medicine and enhance the role of the animal doctor.

Esaote Group Leader in medical imaging (ultrasound, MRI, software to manage the diagnostic process). At the end of 2024, the Group had approximately 1,300 employees, half of whom in Italy. With facilities in Genoa and Florence, and its own production and research units in Italy and the Netherlands, Esaote maintains a presence in over 100 countries around the world. www.esaotevet.com.

© Copyright Esaote 2025

 

EDC launches representation in Thailand, opening new doors for Canadian exporters

With an expanded presence in Southeast Asia, EDC can help Canadian companies seize opportunities in the region’s third-largest market

OTTAWA, ON and BANGKOK, May 26, 2025 /PRNewswire/ — Export Development Canada (EDC) is pleased to announce the opening of its newest Asian representation in Bangkok, Thailand, marking a significant milestone in EDC’s Indo-Pacific strategy. This expansion underscores EDC’s commitment to supporting Canadian businesses in navigating and capitalizing on the dynamic and rapidly evolving Thai market.

Thailand is a key driver of economic growth in Southeast Asia, and as one of the region’s largest economies, boasted a gross domestic product (GDP) of over $500 billion in 2024. The country’s strategic location at the heart of Southeast Asia, coupled with developed infrastructure and a business-friendly environment, makes Thailand an important hub for Canadian trade and investment in the Indo-Pacific region. Canadian exporters have already had success in the market, growing trade to Thailand by $1 billion, or 17%, between 2019 and 2024.

“EDC has long focused on trade diversification to help Canadian companies seize opportunities beyond our traditional markets,” said Alison Nankivell, President and CEO, EDC. “The new representation in Bangkok is part of EDC’s broader Indo-Pacific strategy, aimed at investing in resources and relationships that align with both Canadian strengths and Thailand’s economic and sustainability priorities. For companies looking to diversify into the Thai market or to establish a long-term presence, we’re here to help you.”

This newly launched representation in Bangkok will provide vital assistance for Canadian exporters, helping these companies navigate the Thai market and seize on the country’s growth opportunities. Agri-food, infrastructure, aerospace and clean technology are key sectors for Canadian exporters in Thailand. In 2024, EDC supported over 200 customers in Thailand, helping generate more than $350 million in business, and with potential for much more. Southeast Asia is a region with strong potential and has emerged as a priority market for Canadian companies.

EDC’s financing, insurance and knowledge solutions are designed to help companies manage trade-related risks, expand internationally and reach new markets. Our in-market staff in both Canada and in the Indo-Pacific region collaborate closely with Government of Canada trade partners, working alongside the Trade Commissioner Service and Global Affairs Canada to help Canadian exporters navigate the challenges of entering new markets and capitalize on growth opportunities in key sectors.

“Thailand’s strategic location and robust economic growth make it a valuable trade and investment partner for Canada in the Indo-Pacific region,” said Sara Wilshaw, Senior Assistant Deputy Minister International Trade, and Chief Trade Commissioner Global Affairs Canada. “EDC’s new presence in Bangkok aligns with the Government of Canada’s broader strategy to strengthen bilateral trade relations and support Canadian companies as they explore new opportunities in this vibrant market.”

Canada and Thailand share a robust trade relationship, with bilateral trade upwards of $6 billion in 2024. Thailand’s participation in the Association of Southeast Asian Nations (ASEAN) Free Trade Area and Canada’s involvement in the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) strengthen trade positions in the region. With Thailand’s commitment to achieving carbon neutrality by 2050 and net-zero emissions by 2065, there are significant opportunities for Canadian companies specializing in renewable energy, energy efficiency solutions and sustainable technologies.

The new Bangkok representation, led by Chief Representative Cindy Lim, complements EDC’s existing Indo-Pacific representations in New Delhi, Mumbai, Shanghai, Beijing, Jakarta, Seoul, Tokyo, Ho Chi Minh City, Manila, Sydney as well as a branch in Singapore.   

About EDC

Export Development Canada (EDC) is a financial Crown corporation dedicated to helping Canadian businesses make an impact at home and abroad. EDC has the financial products and knowledge Canadian companies need to confidently enter new markets, reduce financial risk and grow their business as they go from local to global. Together, EDC and Canadian companies are building a more prosperous, stronger and sustainable economy for all Canadians. 

For more information and to learn how we can help your company, call us at 1-800-229-0575 or visit www.edc.ca .

Vibracoustic Selects DXC to Lead Global Business Transformation with SAP

ASHBURN, Va., May 26, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced a multi-year IT services agreement with Vibracoustic, a leading expert in automotive Noise, Vibration, and Harshness (NVH) solutions to transform its SAP environment and modernize global IT operations.

Vibracoustic Selects DXC to Lead Global Business Transformation with SAP
Vibracoustic Selects DXC to Lead Global Business Transformation with SAP

Under the five-year agreement, DXC will become Vibracoustic’s strategic partner for SAP services, taking responsibility for the company’s global SAP Application Development and Management Services (ADMS) across 17 countries and over 30 manufacturing facilities. The transformation will streamline operations, standardize processes, and improve service delivery for more than 5,000 users.

“DXC’s unparalleled expertise in SAP solutions, its ability to manage complex global IT systems, and client-centric approach make it the ideal partner,” said Nico Klohr, Commodity IT Manager at Vibracoustic. “With DXC’s support, we are confident in achieving a unified and efficient SAP service landscape that will further enhance productivity and drive growth.”

By consolidating multiple existing vendors into a single, integrated global service led by DXC, Vibracoustic aims to reduce complexity, enhance consistency, and accelerate innovation.

“With over 15,000 SAP professionals worldwide and over 5 million SAP users supported globally, DXC is a leading provider of SAP solutions, helping businesses to quickly respond to market dynamics, simplify operations, and minimize the disruption, risks and costs of enterprise transformation,” said Juan Parra, President, DXC Europe. “As Vibracoustic’s global strategic supplier, we will manage its mission-critical SAP systems and help to drive greater efficiency across the organization.”

This agreement underscores DXC’s position as a leader in major IT transformations, reaffirmed by its recent recognition in PAC’s SAP Services Europe report as well as Whitelane Research’s 2024/2025 European IT Sourcing Study.

DXC has over 35 years of experience delivering SAP solutions, with a global team of 15,000+ SAP professionals and 2,500+ SAP certifications. DXC supports nearly 850 SAP customers across 60 countries, helping customers simplify operations, scale efficiently, and drive innovation through end-to-end SAP transformation strategies. To learn more, visit DXC.com

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission-critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services to drive new levels of performance, competitiveness, and customer experience across their IT estates. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.

About Vibracoustic

Vibracoustic is a leading global automotive NVH expert, providing customized solutions adding comfort and supporting efficiency, safety and durability. Its expertise along the entire product life cycle and all vehicle systems as well as its broad product range enable Vibracoustic to solve current and future NVH challenges across all automotive segments. With approximately 12,000 employees at around 40 production and engineering locations across 17 countries, Vibracoustic serves all major automotive manufacturers. In 2024 Vibracoustic recorded total sales of 2.6 billion €. For more information, see www.vibracoustic.com

Forward Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that any result, goal or plan set forth in any forward-looking statement can or will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. For a written description of these factors, see the section titled “Risk Factors” in DXC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and any updating information in subsequent SEC filings. Readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.

Contact: Angelena Abate | +1 646 234 8060 | angelena.abate@dxc.com

 

 

Bangkok Ranked Among Most Fraudulent Cities for Car Services

People are in line at the airport (Photo: The Nation)

Bangkok has been named one of the world’s four most fraudulent cities for car-related services, including taxis, tuk-tuks, and rental vehicles.

TWSE and GrandTech Cloud Host F2SU Asia IPO Forum to Showcase Taiwan’s Capital Market Strength

TAIPEI, May 26, 2025 /PRNewswire/ — Taiwan Stock Exchange (the TWSE), in partnership with GrandTech Cloud Services Inc., co-hosted the “F2SU Asia IPO Synergy” forum on Friday. The event aimed to attract Asian startups and showcase Taiwan’s fundraising potential. As part of the “A Friend to Startups (F2SU)” initiative, the forum brought together startups and venture capitalists from across Asia, highlighting the TWSE’s commitment to supporting high-growth companies.

The TWSE welcomed a delegation of 15 representatives from innovative companies across the region during the forum’s morning session, where participants exchanged insights on Taiwan’s capital market. The TWSE Chairman and CEO Sherman Lin said that the Taiwan Innovation Board (TIB) is designed to support high-potential, globally minded companies with flexible listing criteria and a specialized review process. “Our goal is to enhance visibility, strengthen fundraising capacity, and broaden access to growth capital – helping innovative companies grow and stand out in the market,” he said.

The TWSE President Edith Lee, speaking at the evening reception, highlighted that the TWSE offers a wide range of tailored services for innovative companies, ranging from pre-IPO consultation and guidance to post-listing support such as investor relations (IR) platforms and ESG resources aligned with global standards. These initiatives reflect the TWSE’s firm commitment to fostering innovation. 

Frankie Hsu, Chairman of GrandTech Cloud Services, praised Taiwan’s capital market for effectively supporting the growth of innovative industries. James C.J. Hsiao, Director General of Department of Industrial Development at the National Development Council, added that the government continues to channel significant resources into innovation — spanning funding, global talent recruitment, and overseas expansion facilitation. With cross-sector collaboration, the development of Taiwan’s innovation ecosystem is expected to accelerate further.

Two keynote speakers also shared their valuable insights and perspectives. Alice Chang, founder of U.S.-listed beauty tech firm Perfect Corp., shared her IPO experience and outlined several advantages of listing in Taiwan. Jamie Lin, Chairman of AppWorks, highlighted Taiwan’s strengths beyond electronics and AI supply chains, citing high market liquidity, strong price-to-book (P/B) ratios, and substantial foreign ownership as key reasons why Taiwan is an attractive IPO destination. Both speakers affirmed the potential of Taiwan’s capital market.

As of April 2025, Taiwan’s equity market had a total capitalization of NT$65.09 trillion (approx. US$2.24 trillion), with an average daily turnover of NT$308.3 billion (US$10.63 billion), reflecting strong liquidity and growing international appeal.

Taiwan’s P/B ratio stood at 2.19 in March — outperforming Japan (1.84), Korea (0.84), Hong Kong (1.31), and Singapore (1.29) — highlighting its valuation strength among regional markets. The P/B ratio on Taiwan’s Innovation Board reached 3.95, reflecting robust investor appetite for growth companies and affirming the platform’s role in emphasizing the intrinsic value of emerging enterprises.

To expand its reach in Asia, the TWSE, in collaboration with GrandTech Cloud Services, invited regional startups to join the forum, further extending the influence of Taiwan’s Innovation Board. The TWSE has also partnered with KPMG Taiwan to launch the “Southeast Asia Innovation Capital Platform”, holding roadshows in Singapore and Malaysia, with another planned for early July. This initiative aims to deepen ties with Southeast Asian startups and investors.

The forum drew strong participation from media, startups, and venture capital firms across the region. Attendees actively engaged with the TWSE representatives to explore listing opportunities and gain deeper insights into Taiwan’s capital market mechanisms and advantages. The event also helped raise the profile of Taiwan’s capital market in the region. The TWSE said that it will continue collaborating with innovative companies to chart the next stage of growth.

(From left to right) Frankie Hsu, Chairman of GrandTech Cloud Services, and Sherman Lin, Chairman of the TWSE
(From left to right) Frankie Hsu, Chairman of GrandTech Cloud Services, and Sherman Lin, Chairman of the TWSE

(From left to right) Alice Chang, founder of Perfect Corp, James C.J. Hsiao, Director General of Department of Industrial Development at the National Development Council, Edith Lee, President of the TWSE, Frankie Hsu, Chairman of GrandTech Cloud Services, Jamie Lin, Chairman of AppWorks
(From left to right) Alice Chang, founder of Perfect Corp, James C.J. Hsiao, Director General of Department of Industrial Development at the National Development Council, Edith Lee, President of the TWSE, Frankie Hsu, Chairman of GrandTech Cloud Services, Jamie Lin, Chairman of AppWorks

About TWSE

The Taiwan Stock Exchange (the “TWSE”) started operations on February 9, 1962. The TWSE is responsible for operating and advancing the Taiwan securities market. The TWSE’s primary business operations include listing, trading, settlement, and surveillance. These comprise listing promotion and review, post-listing supervision and corporate governance, maintaining market trading and order, securities firms’ services, investor protection, clearing and settlement operations, safeguarding against market defaults and the monitoring of illegal transactions. The Exchange provides comprehensive services to the securities market.

Cambridge English Qualifications Digital: Empowering Schools, Universities, and International Students with a Smarter Way to Certify English Proficiency

SINGAPORE, May 26, 2025 /PRNewswire/ — In today’s global academic landscape, the ability to demonstrate English proficiency with speed, flexibility, and confidence is more important than ever. Cambridge English Qualifications Digital, developed by Cambridge English (part of the University of Cambridge), offers a modern, computer-based exam experience that meets the evolving needs of educational institutions and international learners.

Designed for students from A2 Key to C2 Proficiency, these digital qualifications provide the same trusted content and rigorous standards as traditional paper-based exams, while introducing a range of digital enhancements that make the testing process more accessible, efficient, and student-friendly. Whether preparing for university admission, applying for international study programs, or meeting graduation requirements, Cambridge English Qualifications Digital helps learners showcase their language skills with confidence and credibility.

For schools and universities, the digital format offers greater scheduling flexibility, faster results, and a streamlined exam experience that aligns with the digital learning environments students are already familiar with. For international students, it provides a globally recognised certification that supports academic mobility and opens doors to higher education and career opportunities worldwide.

A Seamless Fit for Modern Education

Cambridge English Qualifications Digital are designed to integrate effortlessly into the academic calendar and digital infrastructure of schools and universities. With more exam dates and locations available, institutions can offer students greater choice and convenience, reducing scheduling conflicts and administrative overhead.

The digital format also supports faster turnaround times for results, enabling institutions to make timely decisions on admissions, course placements, and graduation eligibility. This is especially valuable for international students who often face tight deadlines for visa applications, scholarship submissions, or university enrolment.

“The digital exams have made it easier for us to plan around our academic calendar. Students appreciate the flexibility, and we appreciate the efficiency,” says the Director of Language Programs at a leading European university.

Designed for Digital Natives

Today’s students are digital natives. They learn, communicate, and collaborate in digital environments—and they expect their assessments to reflect that reality. Cambridge English Qualifications Digital are built with this in mind, offering a user-friendly interface and intuitive tools that help students perform at their best.

Watch the video:
The preferred exam experience | Cambridge English Qualifications Digital

Key Features:

  • Listening Test: Candidates use headphones with individual volume control, ensuring a comfortable and distraction-free experience.
  • Writing Test: Features like automatic word count, spell check, and easy editing allow candidates to focus on content rather than formatting.
  • Reading Test: On-screen tools enable highlighting, note-taking, and answer review, helping candidates manage their time and strategy effectively.
  • Speaking Test: Remains face-to-face, preserving the real-world communication skills that Cambridge English is known for.

These features not only enhance the candidate experience but also reflect the digital communication skills students will need in academic and professional settings.

Trusted by Educators, Preferred by Students

Cambridge English Qualifications Digital are already being used by schools and universities around the world, with overwhelmingly positive feedback from both educators and learners.

“It’s all advantages for candidates. They like doing it. My students keep coming back to do more exams,” says Alex, a teacher from Spain.

“The digital format really helps students feel more confident. They’re used to typing and navigating screens—it’s second nature to them,” adds Selin, a teacher in Turkey.

For educators, the digital exams offer a reliable and scalable solution that aligns with modern teaching practices. For students, they provide a familiar and empowering way to demonstrate their language skills.

No Need to Change How You Teach

One of the most reassuring aspects for schools and universities is that the digital exams test the same knowledge and skills as the paper-based versions. This means there’s no need to overhaul teaching methods or materials. Teachers can continue using their existing coursebooks and lesson plans while integrating digital practice tools to help students become familiar with the exam format.

Cambridge English also provides a wide range of free and premium preparation resources to support both classroom instruction and independent study.

Powerful Digital Preparation Tools

To help students prepare effectively, Cambridge English offers a suite of digital tools that mirror the exam experience and build confidence:

“Test & Train is really useful because students can practise on the go. If they have it on their phone, they can even be sitting on the bus or the metro and do a few exercises,” says Sarah, an Examination Centre Deputy Director.

These tools not only improve exam readiness but also support broader language development goals.

Supporting International Students

For international students, Cambridge English Qualifications Digital offer a fast, flexible, and globally recognised way to prove English proficiency. Whether applying to universities in the UK, Australia, Canada, or beyond, these qualifications are accepted by thousands of institutions worldwide.

The digital format also helps reduce logistical barriers. Students can choose from a wider range of test dates and locations, and receive their results more quickly – making it easier to meet application deadlines and visa requirements.

“Having access to a digital exam meant I could take the test in my home country and still meet my university’s deadline. It made the whole process much less stressful,” says Amina, an international student from Morocco.

A Commitment to Quality and Innovation

As part of the University of Cambridge, Cambridge English is committed to maintaining the highest standards of academic integrity, fairness, and innovation. The digital exams are developed using cutting-edge research in language assessment and educational technology, ensuring they remain valid, reliable, and globally recognised.

Hybrid marking has also been introduced for the Writing component at B1 and B2 levels, combining human expertise with digital efficiency to deliver accurate and timely results.

Ready to Bring Digital Exams to Your Institution?

Whether you’re a school administrator, university admissions officer, or international student advisor, Cambridge English Qualifications Digital offer a smarter, faster, and more flexible way to support your learners’ success.

Visit cambridgeenglish.org/digital to:

  • Explore exam levels and formats
  • Access free preparation resources
  • Find your nearest exam centre
  • Book your digital exam

************************************************************

About Cambridge English

Cambridge English is the producer and proud co-owner of IELTS, the world’s leading English test for migration and higher education. We help millions of people learn English and prove their skills to the world.

Part of the University of Cambridge, we provide the world’s leading range of qualifications and tests for learners and teachers of English. For us, learning English is more than just exams and grades. It’s about having the confidence to communicate and access a lifetime of enriching experiences and opportunities.

Whether you’re planning to live, work or study in your own country or abroad, we can give you the English language skills to succeed. We provide the world’s leading range of qualifications and tests for learners and teachers of English. Globally recognised by more than 25,000 leading universities, employers and governments, our research-based assessments are a mark of excellence that open doors.

Our work is supported around the world by a network of 2,800 exam centres, over 50,000 schools and tens of thousands of examiners, teachers, education experts and publishers. Working together, we inspire learners to go further.

With the right support, learning a language is an exhilarating journey. We’re with you every step of the way.

*************************************************************

What we believe – To learn English is to enjoy and experience a language that opens up opportunities across the world.

What we offer – Together with teachers and our partners, we’re here to engage and inspire millions of people throughout their entire English language learning journey, helping them confidently prove their skills to the world.

How we do things and the impact we have  – As part of a university with global reputation for academic excellence, we create insights derived from deep research, expertise and experiences. This ensures our unique approach meets the real-life needs of learners through inclusive and accessible products and services.

The global role of English – As a global language, English unlocks a lifetime of experiences, and – because language is at the heart of being human – we help people everywhere connect, communicate and come closer together.

What we promise – Where your world grows.

– END –

 

Woodfibre LNG Sets New Benchmark as World’s First Net Zero LNG Export Facility

SINGAPORE – Media OutReach Newswire – 26 May 2025 – Woodfibre LNG, a subsidiary of Pacific Energy which is a member of the Royal Golden Eagle (RGE) group of companies, is setting a new benchmark for responsible natural gas export. At its new liquefied natural gas (LNG) facility under development in British Columbia, the company is on track to become the world’s first net zero LNG export facility – achieving net zero not only during operations, but also throughout the construction phase.

This groundbreaking commitment to sustainability is being realised through a combination of best-in-class technologies, low-emission operations and nature-based carbon offsets. Together, these efforts are setting a new standard for minimising environmental impact in the global LNG industry.

Ratnesh Bedi, President of Pacific Energy, said, “Achieving net zero emissions means balancing the amount of greenhouse gases emitted with those removed or offset. At Woodfibre LNG, this balance is not theoretical, it’s operational. By integrating advanced emissions-reduction technologies with robust offset strategies, the facility aims to produce LNG with one of the lowest carbon intensities in the world. We are not waiting for the future – we are building it now. This project sets a new standard for how energy can be produced responsibly, and it reflects our long-term commitment to accelerating the global transition to a low-carbon economy while meeting the world’s growing energy needs.”

At the heart of the facility’s emissions reduction is the E-Drive system, which uses electric compressors powered by renewable hydroelectricity for the liquefaction process. This innovation alone is projected to cut more than 230,000 tonnes of CO2e annually – equivalent to taking 70,000 cars off the road.

Other emissions reduction initiatives include re-liquefying boil-off gas to prevent atmospheric release, capable of avoiding over 11,000 tonnes of CO2e per year, and introducing air-cooling systems (replacing traditional seawater cooling), developed in line with the Squamish Nation Environmental Assessment Agreement, which can reduce an additional 3,000 tonnes of CO2e annually. These measures support Woodfibre LNG’s target of achieving a carbon intensity of just 0.04 tonnes of CO2 per tonne of LNG produced, far below the global industry average.

To neutralise any remaining emissions, Woodfibre LNG will purchase locally developed, nature-based carbon offsets from projects affiliated with First Nations partners. These projects focus on forest conservation – protecting vital forest ecosystems that absorb and store carbon dioxide over time. All emissions data and offset projects are validated by Brightspot Climate, ensuring compliance with British Columbia’s stringent regulatory requirements and upholding transparency in reporting.

“Woodfibre LNG’s approach demonstrates that net zero is not just a future goal. It’s achievable today with the right combination of innovation, collaboration and accountability,” said Ratnesh. “We are proud to lead the way in building a cleaner, more responsible energy future.”

The Woodfibre project marks a significant milestone in the global energy transition, proving that LNG can be delivered with a smaller carbon footprint – without compromising performance, safety or environmental stewardship.
Hashtag: #RGE #RoyalGoldenEagle #WoodfibreLNG #PacificEnergy #liquefiednaturalgas #LNG #NetZero

The issuer is solely responsible for the content of this announcement.